About Angelini Pharma
Angelini Pharma is a Healthcare company based in Rome (Italy) founded in 1919, and was acquired by AFT Pharmaceuticals in January 2017. Manufacturer and developer of active ingredients, branded drugs, medical products and dietary supplements. Angelini Pharma has completed 2 acquisitions, including Arvelle Therapeutics and CatalystPharma. Its chief executive, as recorded, is Jacopo Andreose. Its website angelinipharma.com draws about 36 thousand monthly visits. Angelini Pharma offers products and services including Tantum Verde, Latuda, Acutil, and ThermaCare. Its focus areas include Diversified Pharmaceuticals and Drugs. Its legal entity is Angelini Pharma S.p.a.
Company details
Angelini Pharma is engaged in the manufacturing and marketing of active ingredients, branded drugs, medical products, dietary supplements, and personal hygiene products. The company markets prescription and OTC products in diverse therapeutic areas: analgesia and inflammation, neuropsychiatry, gynecology and infectious diseases. Some of its known brands are Trittico (trazodone), Tantum (benzydamine) and Aulin (nimesulide). The company is selling its supplements under BodySpring and Acutil brand names. The company has three manufacturing plants located in Ancona for finished products, Aprilia for pharmaceutical raw materials, and Casella for the production of Amuchina brand disinfectants.
- Headquarters Rome, Italy
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website angelinipharma.com
- Social LinkedIn X Facebook Instagram
- Acquired by AFT Pharmaceuticals (Jan 2017)
- Legal Name Angelini Pharma S.P.A.
- Investors
- Investments & AcquisitionsArvelle Therapeutics
& 1 more
- Acquired byAFT Pharmaceuticals
(Jan 2017)
Products & Services of Angelini Pharma
Angelini Pharma offers a comprehensive portfolio of products and services, including Tantum Verde, Latuda, Acutil, and ThermaCare.
Sore throat treatment for consumer use.
Medication for bipolar disorder management.
Support for cognitive health functions.
Heat therapy for muscle strain relief.
Investors in Angelini Pharma
Angelini Pharma has secured backing from 1 investor. Prominent investors backing the company include AFT Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Proprietary and in-licensed pharmaceutical products are developed and distributed. | 1997 | aftpharm.com | Auckland, New Zealand |
Investor details for Angelini Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Angelini Pharma
59 people are tracked at Angelini Pharma (16 in leadership, 43 in team).
| Name | Role | Group |
|---|---|---|
Jacopo Andreose | CEO | Leadership |
Silvia Sabatini | Assistant Group Chief HR & Organization Officer | Leadership |
Jacopo Bellini | Chief of Staff | Leadership |
Silvestro Camerini | Pharma Chief, Financial Officer | Leadership |
Rafal Kaminski | Chief Scientific Officer | Leadership |
Andrea Stagno D'Alcontres | Head Of Special Projects | Leadership |
Elena Demetrio | Head Of Innovative Analytical Development | Leadership |
Stefano Brandinali | Chief Innovation Officer | Leadership |
Giuseppe Tino | Group Head Of Org. Development, HRIS & Change | Leadership |
Giorgio di Loreto | Head Of Statistics | Leadership |
Gianluca Bentivegna | Head Of Procurement Excellence | Leadership |
Camilla Cettomai | Group Business Performance & Control Director | Leadership |
Joao Rocha | Finance & Administration Head At Angelini Pharma Portugal | Leadership |
Valentina Valentini | HEAD OF Group Compensation & Performance | Leadership |
Isabella Falautano | Group Chief Sustainability Officer | Leadership |
Luca Mazzetti | Head Of E-commerce, Drugstore & Discount | Leadership |
Ambra Corazza | Lead Buyer Commercial Purchasing | Team |
Alessandra Pennacchiotti | Global Customer Facing Roles Training & Development Senior Manager | Team |
Carola Langella | Technical Property E Compliance Specialist | Team |
Simona Farinelli | Lead Buyer Finished Product | Team |
39 more people are available in the full profile.
Complete people profiles for Angelini Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Angelini Pharma
Angelini Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Arvelle Therapeutics and CatalystPharma.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Therapies for rare neuromuscular and neurological diseases are developed. | catalystpharma.com | Coral Gables, United States | 2002 | May 2026 | $4.1B | |
Small molecule therapies are developed for partial-onset seizures treatment. | arvelletx.com | Zug, Switzerland | 2019 | Jan 2021 | •••• |
Complete acquisition details for Angelini Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Angelini Pharma
4 dated milestones of Angelini Pharma across 107 years, from founding to its latest funding, stage changes and deals.
- Founded Angelini Pharma is founded.
- Exit Acquired by AFT Pharmaceuticals.
- Acquisition Acquires Arvelle Therapeutics.
- Acquisition Acquires CatalystPharma.
Web traffic of Angelini Pharma
The website of Angelini Pharma (angelinipharma.com) receives about 36.1K visits a month and ranks #668,498 among all websites worldwide, #745 in Biotechnology and Pharmaceuticals.
- Monthly visits36.1K
- Unique visitors17.7K
per month
- Global rank#668,498
among all websites
- Category rank#745
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit3.5
- Average visit25 sec
- DevicesDesktop 27% · Mobile 73%
Websites whose visitors overlap most with Angelini Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| sumitomo-pharma.com | 100% | 21.1K | #1,635,262 | View details | |
angelini.pl | angelini.pl | 90% | – | ||
| ibsa.ch | 90% | #4,302,558 | View details | ||
pns.dgs.pt | pns.dgs.pt | 55% | – | ||
moment.it | moment.it | 53% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Angelini Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Angelini Pharma
Complete news archive for Angelini Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Angelini Pharma
Angelini Pharma was founded in 1919.
Angelini Pharma is headquartered in Rome, Italy. It is registered at Rome, Lazio, Italy.
Jacopo Andreose is the CEO of Angelini Pharma, as recorded in our data.
Angelini Pharma is engaged in the manufacturing and marketing of active ingredients, branded drugs, medical products, dietary supplements, and personal hygiene products. The company markets prescription and OTC products in diverse therapeutic areas: analgesia and inflammation, neuropsychiatry, gynecology and infectious diseases. Some of its known brands are Trittico (trazodone), Tantum (benzydamine) and Aulin (nimesulide). The company is selling its supplements under BodySpring and Acutil brand names. The company has three manufacturing plants located in Ancona for finished products, Aprilia for pharmaceutical raw materials, and Casella for the production of Amuchina brand disinfectants.
Angelini Pharma offers Tantum Verde, Latuda, Acutil, and ThermaCare.
Angelini Pharma has made 2 acquisitions, including Arvelle Therapeutics, and CatalystPharma.
Angelini Pharma has 1 investor. Key investors include AFT Pharmaceuticals.
Angelini Pharma operates through Angelini Pharma S.P.A..
Yes. Angelini Pharma was acquired by AFT Pharmaceuticals in January 2017.